Side-by-side comparison of AI visibility scores, market position, and capabilities
Flagship Pioneering-backed scientific superintelligence. Fully autonomous AI labs. $550M raised ($115M from Nvidia). $1.3B+ valuation. Founded 2024, Cambridge MA.
Lila Sciences is a scientific superintelligence company founded in 2024 and headquartered in Cambridge, Massachusetts, with the mission of building fully autonomous AI systems capable of conducting original scientific research. Backed by Flagship Pioneering — the venture creation firm behind Moderna — Lila Sciences is pursuing one of the most ambitious mandates in AI: replacing the human-in-the-loop in the scientific method with AI that can hypothesize, design experiments, interpret results, and iterate without continuous human direction.\n\nLila Sciences operates autonomous AI laboratories that handle the full research cycle: hypothesis generation, experimental design, robotic execution, data analysis, and scientific interpretation. The company is focused initially on life sciences and biology, where the combinatorial search space for drug discovery and therapeutic development has historically been a bottleneck that AI is uniquely suited to accelerate. Unlike AI tools that assist scientists, Lila's systems are designed to function as independent research agents, with human scientists setting research goals and reviewing outputs rather than directing every step.\n\nLila Sciences has raised $550 million in total funding, including $115 million from NVIDIA, reaching a valuation exceeding $1.3 billion. NVIDIA's investment reflects both the compute demands of autonomous lab systems and strategic alignment with the vision of AI-accelerated science. The company is among the best-funded scientific AI startups globally and one of a small cohort — alongside Isomorphic Labs and Genesis Therapeutics — building toward fully autonomous scientific discovery. Its Flagship Pioneering pedigree and early-stage capitalization give Lila a multi-year runway to prove the autonomous research paradigm.
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.